Entegris, Inc. (ENTG) Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. increased its stake in Entegris, Inc. (NASDAQ:ENTG) by 22.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 269,909 shares of the semiconductor company’s stock after buying an additional 50,220 shares during the period. Russell Investments Group Ltd. owned 0.19% of Entegris worth $6,316,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of ENTG. Norges Bank purchased a new position in shares of Entegris during the fourth quarter worth $20,982,000. Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Entegris during the third quarter worth $8,233,000. FMR LLC raised its stake in shares of Entegris by 74.7% in the fourth quarter. FMR LLC now owns 935,800 shares of the semiconductor company’s stock worth $16,751,000 after buying an additional 400,000 shares in the last quarter. Teachers Advisors LLC raised its stake in shares of Entegris by 50.2% in the fourth quarter. Teachers Advisors LLC now owns 1,122,845 shares of the semiconductor company’s stock worth $20,099,000 after buying an additional 375,065 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in Entegris by 54.0% in the fourth quarter. Renaissance Technologies LLC now owns 1,023,390 shares of the semiconductor company’s stock valued at $18,319,000 after buying an additional 358,700 shares in the last quarter. Institutional investors and hedge funds own 97.86% of the company’s stock.

Institutional Ownership by Quarter for Entegris (NASDAQ:ENTG)

Entegris, Inc. (NASDAQ:ENTG) traded up 0.42% during mid-day trading on Monday, hitting $24.15. The stock had a trading volume of 1,087,982 shares. The firm has a 50-day moving average of $24.72 and a 200-day moving average of $21.63. The stock has a market cap of $3.42 billion, a P/E ratio of 30.19 and a beta of 1.45. Entegris, Inc. has a 52-week low of $13.41 and a 52-week high of $27.20.

Entegris (NASDAQ:ENTG) last announced its quarterly earnings results on Thursday, April 27th. The semiconductor company reported $0.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.25 by $0.03. Entegris had a return on equity of 16.65% and a net margin of 9.26%. The firm had revenue of $317.40 million during the quarter, compared to analyst estimates of $304.62 million. During the same quarter in the previous year, the business earned $0.17 EPS. Entegris’s revenue for the quarter was up 18.9% compared to the same quarter last year. On average, analysts forecast that Entegris, Inc. will post $1.16 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Entegris, Inc. (ENTG) Shares Bought by Russell Investments Group Ltd.” was first posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://baseballnewssource.com/markets/russell-investments-group-ltd-acquires-50220-shares-of-entegris-inc-entg-updated-updated/862671.html.

A number of research analysts have issued reports on ENTG shares. Needham & Company LLC upgraded Entegris from a “hold” rating to a “buy” rating and set a $25.00 price objective for the company in a research note on Monday, March 13th. Aegis initiated coverage on Entegris in a research note on Friday, March 17th. They issued a “buy” rating and a $29.00 price target for the company. Citigroup Inc. upped their price objective on Entegris from $21.00 to $24.00 and gave the company a “neutral” rating in a research report on Monday, March 20th. Dougherty & Co boosted their price target on Entegris from $26.50 to $27.50 and gave the company a “buy” rating in a report on Friday, April 28th. Finally, Craig Hallum lowered Entegris from a “buy” rating to a “hold” rating in a research note on Friday, April 28th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $24.81.

In related news, SVP Gregory Bryan Marshall sold 11,765 shares of Entegris stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $25.03, for a total value of $294,477.95. Following the sale, the senior vice president now directly owns 15,241 shares in the company, valued at approximately $381,482.23. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Todd James Edlund sold 19,116 shares of Entegris stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $25.02, for a total value of $478,282.32. Following the completion of the sale, the chief operating officer now owns 160,610 shares in the company, valued at $4,018,462.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 52,036 shares of company stock worth $1,301,229. 1.70% of the stock is currently owned by insiders.

Entegris Company Profile

Entegris, Inc is a global developer, manufacturer and supplier of microcontamination control products, specialty chemicals and materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries. The Company operates in three business segments: Specialty Chemicals and Engineered Materials (SCEM), Advanced Materials Handling (AMH) and Microcontamination Control (MC).

Receive News & Ratings for Entegris Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entegris Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.